|
| | HB2383 Enrolled | - 2 - | LRB100 00361 RLC 10365 b |
|
|
1 | | for staff who work in day programs that are similar to those |
2 | | for staff who work in residential programs. This training |
3 | | program shall be developed in consultation with professional
|
4 | | associations representing (i) physicians licensed to practice |
5 | | medicine in all
its branches, (ii) registered professional |
6 | | nurses, and (iii) pharmacists.
|
7 | | (b) For the purposes of this Section:
|
8 | | "Authorized direct care staff" means non-licensed persons |
9 | | who have
successfully completed a medication administration |
10 | | training program
approved by the Department of Human Services |
11 | | and conducted by a nurse-trainer.
This authorization is |
12 | | specific to an individual receiving service in
a
specific |
13 | | agency and does not transfer to another agency.
|
14 | | "Medications" means oral and topical medications, insulin |
15 | | in an injectable form, oxygen, epinephrine auto-injectors, and |
16 | | vaginal and rectal creams and suppositories. "Oral" includes |
17 | | inhalants and medications administered through enteral tubes, |
18 | | utilizing aseptic technique. "Topical" includes eye, ear, and |
19 | | nasal medications. Any controlled substances must be packaged |
20 | | specifically for an identified individual. |
21 | | "Insulin in an injectable form" means a subcutaneous |
22 | | injection via an insulin pen pre-filled by the manufacturer. |
23 | | Authorized direct care staff may administer insulin, as ordered |
24 | | by a physician, advanced practice nurse, or physician |
25 | | assistant, if: (i) the staff has successfully completed a |
26 | | Department-approved advanced training program specific to |
|
| | HB2383 Enrolled | - 3 - | LRB100 00361 RLC 10365 b |
|
|
1 | | insulin administration developed in consultation with |
2 | | professional associations listed in subsection (a) of this |
3 | | Section, and (ii) the staff consults with the registered nurse, |
4 | | prior to administration, of any insulin dose that is determined |
5 | | based on a blood glucose test result. The authorized direct |
6 | | care staff shall not: (i) calculate the insulin dosage needed |
7 | | when the dose is dependent upon a blood glucose test result, or |
8 | | (ii) administer insulin to individuals who require blood |
9 | | glucose monitoring greater than 3 times daily, unless directed |
10 | | to do so by the registered nurse. |
11 | | "Nurse-trainer training program" means a standardized, |
12 | | competency-based
medication administration train-the-trainer |
13 | | program provided by the
Department of Human Services and |
14 | | conducted by a Department of Human
Services master |
15 | | nurse-trainer for the purpose of training nurse-trainers to
|
16 | | train persons employed or under contract to provide direct care |
17 | | or
treatment to individuals receiving services to administer
|
18 | | medications and provide self-administration of medication |
19 | | training to
individuals under the supervision and monitoring of |
20 | | the nurse-trainer. The
program incorporates adult learning |
21 | | styles, teaching strategies, classroom
management, and a |
22 | | curriculum overview, including the ethical and legal
aspects of |
23 | | supervising those administering medications.
|
24 | | "Self-administration of medications" means an individual |
25 | | administers
his or her own medications. To be considered |
26 | | capable to self-administer
their own medication, individuals |
|
| | HB2383 Enrolled | - 4 - | LRB100 00361 RLC 10365 b |
|
|
1 | | must, at a minimum, be able to identify
their medication by |
2 | | size, shape, or color, know when they should take
the |
3 | | medication, and know the amount of medication to be taken each |
4 | | time.
|
5 | | "Training program" means a standardized medication |
6 | | administration
training program approved by the Department of |
7 | | Human Services and
conducted by a registered professional nurse |
8 | | for the purpose of training
persons employed or under contract |
9 | | to provide direct care or treatment to
individuals receiving |
10 | | services to administer medications
and provide |
11 | | self-administration of medication training to individuals |
12 | | under
the delegation and supervision of a nurse-trainer. The |
13 | | program incorporates
adult learning styles, teaching |
14 | | strategies, classroom management,
curriculum overview, |
15 | | including ethical-legal aspects, and standardized
|
16 | | competency-based evaluations on administration of medications |
17 | | and
self-administration of medication training programs.
|
18 | | (c) Training and authorization of non-licensed direct care |
19 | | staff by
nurse-trainers must meet the requirements of this |
20 | | subsection.
|
21 | | (1) Prior to training non-licensed direct care staff to |
22 | | administer
medication, the nurse-trainer shall perform the |
23 | | following for each
individual to whom medication will be |
24 | | administered by non-licensed
direct care staff:
|
25 | | (A) An assessment of the individual's health |
26 | | history and
physical and mental status.
|
|
| | HB2383 Enrolled | - 5 - | LRB100 00361 RLC 10365 b |
|
|
1 | | (B) An evaluation of the medications prescribed.
|
2 | | (2) Non-licensed authorized direct care staff shall |
3 | | meet the
following criteria:
|
4 | | (A) Be 18 years of age or older.
|
5 | | (B) Have completed high school or have a high |
6 | | school equivalency certificate.
|
7 | | (C) Have demonstrated functional literacy.
|
8 | | (D) Have satisfactorily completed the Health and |
9 | | Safety
component of a Department of Human Services |
10 | | authorized
direct care staff training program.
|
11 | | (E) Have successfully completed the training |
12 | | program,
pass the written portion of the comprehensive |
13 | | exam, and score
100% on the competency-based |
14 | | assessment specific to the
individual and his or her |
15 | | medications.
|
16 | | (F) Have received additional competency-based |
17 | | assessment
by the nurse-trainer as deemed necessary by |
18 | | the nurse-trainer
whenever a change of medication |
19 | | occurs or a new individual
that requires medication |
20 | | administration enters the program.
|
21 | | (3) Authorized direct care staff shall be re-evaluated |
22 | | by a
nurse-trainer at least annually or more frequently at |
23 | | the discretion of
the registered professional nurse. Any |
24 | | necessary retraining shall be
to the extent that is |
25 | | necessary to ensure competency of the authorized
direct |
26 | | care staff to administer medication.
|
|
| | HB2383 Enrolled | - 6 - | LRB100 00361 RLC 10365 b |
|
|
1 | | (4) Authorization of direct care staff to administer |
2 | | medication
shall be revoked if, in the opinion of the |
3 | | registered professional nurse,
the authorized direct care |
4 | | staff is no longer competent to administer
medication.
|
5 | | (5) The registered professional nurse shall assess an
|
6 | | individual's health status at least annually or more |
7 | | frequently at the
discretion of the registered |
8 | | professional nurse.
|
9 | | (d) Medication self-administration shall meet the |
10 | | following
requirements:
|
11 | | (1) As part of the normalization process, in order for |
12 | | each
individual to attain the highest possible level of |
13 | | independent
functioning, all individuals shall be |
14 | | permitted to participate in their
total health care |
15 | | program. This program shall include, but not be
limited to, |
16 | | individual training in preventive health and |
17 | | self-medication
procedures.
|
18 | | (A) Every program shall adopt written policies and
|
19 | | procedures for assisting individuals in obtaining |
20 | | preventative
health and self-medication skills in |
21 | | consultation with a
registered professional nurse, |
22 | | advanced practice nurse,
physician assistant, or |
23 | | physician licensed to practice medicine
in all its |
24 | | branches.
|
25 | | (B) Individuals shall be evaluated to determine |
26 | | their
ability to self-medicate by the nurse-trainer |
|
| | HB2383 Enrolled | - 7 - | LRB100 00361 RLC 10365 b |
|
|
1 | | through the use of
the Department's required, |
2 | | standardized screening and assessment
instruments.
|
3 | | (C) When the results of the screening and |
4 | | assessment
indicate an individual not to be capable to |
5 | | self-administer his or her
own medications, programs |
6 | | shall be developed in consultation
with the Community |
7 | | Support Team or Interdisciplinary
Team to provide |
8 | | individuals with self-medication
administration.
|
9 | | (2) Each individual shall be presumed to be competent |
10 | | to self-administer
medications if:
|
11 | | (A) authorized by an order of a physician licensed |
12 | | to
practice medicine in all its branches, an advanced |
13 | | practice nurse, or a physician assistant; and
|
14 | | (B) approved to self-administer medication by the
|
15 | | individual's Community Support Team or
|
16 | | Interdisciplinary Team, which includes a registered
|
17 | | professional nurse or an advanced practice nurse.
|
18 | | (e) Quality Assurance.
|
19 | | (1) A registered professional nurse, advanced practice |
20 | | nurse,
licensed practical nurse, physician licensed to |
21 | | practice medicine in all
its branches, physician |
22 | | assistant, or pharmacist shall review the
following for all |
23 | | individuals:
|
24 | | (A) Medication orders.
|
25 | | (B) Medication labels, including medications |
26 | | listed on
the medication administration record for |
|
| | HB2383 Enrolled | - 8 - | LRB100 00361 RLC 10365 b |
|
|
1 | | persons who are not
self-medicating to ensure the |
2 | | labels match the orders issued by
the physician |
3 | | licensed to practice medicine in all its branches,
|
4 | | advanced practice nurse, or physician assistant.
|
5 | | (C) Medication administration records for persons |
6 | | who
are not self-medicating to ensure that the records |
7 | | are completed
appropriately for:
|
8 | | (i) medication administered as prescribed;
|
9 | | (ii) refusal by the individual; and
|
10 | | (iii) full signatures provided for all |
11 | | initials used.
|
12 | | (2) Reviews shall occur at least quarterly, but may be |
13 | | done
more frequently at the discretion of the registered |
14 | | professional nurse
or advanced practice nurse.
|
15 | | (3) A quality assurance review of medication errors and |
16 | | data
collection for the purpose of monitoring and |
17 | | recommending
corrective action shall be conducted within 7 |
18 | | days and included in the
required annual review.
|
19 | | (f) Programs using authorized direct care
staff to |
20 | | administer medications are responsible for documenting and |
21 | | maintaining
records
on the training that is completed.
|
22 | | (g) The absence of this training program constitutes a |
23 | | threat to the
public interest,
safety, and welfare and |
24 | | necessitates emergency rulemaking by
the Departments of Human |
25 | | Services and
Public Health
under Section 5-45
of
the
Illinois |
26 | | Administrative Procedure Act.
|
|
| | HB2383 Enrolled | - 9 - | LRB100 00361 RLC 10365 b |
|
|
1 | | (h) Direct care staff who fail to qualify for delegated |
2 | | authority to
administer medications pursuant to the provisions |
3 | | of this Section shall be
given
additional education and testing |
4 | | to meet criteria for
delegation authority to administer |
5 | | medications.
Any direct care staff person who fails to qualify |
6 | | as an authorized direct care
staff
after initial training and |
7 | | testing must within 3 months be given another
opportunity for |
8 | | retraining and retesting. A direct care staff person who fails
|
9 | | to
meet criteria for delegated authority to administer |
10 | | medication, including, but
not limited to, failure of the |
11 | | written test on 2 occasions shall be given
consideration for |
12 | | shift transfer or reassignment, if possible. No employee
shall |
13 | | be terminated for failure to qualify during the 3-month time |
14 | | period
following initial testing. Refusal to complete training |
15 | | and testing required
by this Section may be grounds for |
16 | | immediate dismissal.
|
17 | | (i) No authorized direct care staff person delegated to |
18 | | administer
medication shall be subject to suspension or |
19 | | discharge for errors
resulting from the staff
person's acts or |
20 | | omissions when performing the functions unless the staff
|
21 | | person's actions or omissions constitute willful and wanton |
22 | | conduct.
Nothing in this subsection is intended to supersede |
23 | | paragraph (4) of subsection
(c).
|
24 | | (j) A registered professional nurse, advanced practice |
25 | | nurse,
physician licensed to practice medicine in all its |
26 | | branches, or physician
assistant shall be on
duty or
on call at |
|
| | HB2383 Enrolled | - 10 - | LRB100 00361 RLC 10365 b |
|
|
1 | | all times in any program covered by this Section.
|
2 | | (k) The employer shall be responsible for maintaining |
3 | | liability insurance
for any program covered by this Section.
|
4 | | (l) Any direct care staff person who qualifies as |
5 | | authorized direct care
staff pursuant to this Section shall be |
6 | | granted consideration for a one-time
additional
salary |
7 | | differential. The Department shall determine and provide the |
8 | | necessary
funding for
the differential in the base. This |
9 | | subsection (l) is inoperative on and after
June 30, 2000.
|
10 | | (Source: P.A. 98-718, eff. 1-1-15; 98-901, eff. 8-15-14; 99-78, |
11 | | eff. 7-20-15; 99-143, eff. 7-27-15; 99-581, eff. 1-1-17 .)
|
12 | | Section 10. The MC/DD Act is amended by adding Section |
13 | | 3-301.1 as follows: |
14 | | (210 ILCS 46/3-301.1 new) |
15 | | Sec. 3-301.1. Administration of medication by direct care |
16 | | staff at day programs. For the purposes of this Act, violations |
17 | | cited against a facility as a result of actions involving |
18 | | administration of medication by direct care staff of day |
19 | | programs certified to serve persons with developmental |
20 | | disabilities by the Department of Human Services under Section |
21 | | 15.4 of the Mental Health and Developmental Disabilities |
22 | | Administrative Act will not result in: |
23 | | (1) the facility being issued a "Type AA" violation as |
24 | | defined in Section 1-128.5 of this Act; |
|
| | HB2383 Enrolled | - 11 - | LRB100 00361 RLC 10365 b |
|
|
1 | | (2) the facility being issued a "Type A" violation as |
2 | | defined in Section 1-129 of this Act; |
3 | | (3) the facility being issued a "Type B" violation as |
4 | | defined in Section 1-130 of this Act; |
5 | | (4) denial of the facility's license under Section |
6 | | 3-117 of this Act; |
7 | | (5) the facility being placed on the Department's |
8 | | quarterly list of facilities which the Department has taken |
9 | | action against prepared under Section 3-304 of this Act; |
10 | | (6) the facility being assessed a penalty or fine under |
11 | | Section 3-305 of this Act; |
12 | | (7) the facility being issued a conditional license |
13 | | under Section 3-311 of this Act; or |
14 | | (8) the Department's suspension or revocation of a |
15 | | facility's license or refusal to renew a facility's license |
16 | | under Section 3-119 of this Act. |
17 | | The Department shall notify the Division of Developmental |
18 | | Disabilities of the Department of Human Services when it |
19 | | becomes aware of a medication error at a day program or that a |
20 | | resident is injured or is subject to alleged abuse or neglect |
21 | | at a day program. |
22 | | Section 15. The ID/DD Community Care Act is amended by |
23 | | adding Section 3-301.1 as follows: |
24 | | (210 ILCS 47/3-301.1 new) |
|
| | HB2383 Enrolled | - 12 - | LRB100 00361 RLC 10365 b |
|
|
1 | | Sec. 3-301.1. Administration of medication by direct care |
2 | | staff at day programs. For the purposes of this Act, violations |
3 | | cited against a facility as a result of actions involving |
4 | | administration of medication by direct care staff of day |
5 | | programs certified to serve persons with developmental |
6 | | disabilities by the Department of Human Services under Section |
7 | | 15.4 of the Mental Health and Developmental Disabilities |
8 | | Administrative Act will not result in: |
9 | | (1) the facility being issued a "Type AA" violation as |
10 | | defined in Section 1-128.5 of this Act; |
11 | | (2) the facility being issued a "Type A" violation as |
12 | | defined in Section 1-129 of this Act; |
13 | | (3) the facility being issued a "Type B" violation as |
14 | | defined in Section 1-130 of this Act; |
15 | | (4) denial of the facility's license under Section |
16 | | 3-117 of this Act; |
17 | | (5) the facility being placed on the Department's |
18 | | quarterly list of facilities which the Department has taken |
19 | | action against prepared under Section 3-304 of this Act; |
20 | | (6) the facility being assessed a penalty or fine under |
21 | | Section 3-305 of this Act; |
22 | | (7) the facility being issued a conditional license |
23 | | under Section 3-311 of this Act; or |
24 | | (8) the Department's suspension or revocation of a |
25 | | facility's license or refusal to renew a facility's license |
26 | | under Section 3-119 of this Act. |